Quidelortho Corp (QDEL)

$15.24 -1.33 (-8.03%)
Market Cap 1.16B
Revenue (ttm) 2.73B
Net Income (ttm) -1.13B
EPS (ttm) N/A
PE Ratio 8.03
Forward PE 7.81
Profit Margin -41.45%
Debt to Equity Ratio 1.38
Volume 3,485,700
Avg Vol 1,332,396
Day's Range N/A - N/A
Shares Out 68.08M
Stochastic %K 3%
Beta 0.75
Analysts Sell
Price Target $34.67

Company Profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibo...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 552 1100
Fax: 858 453 4338
Address:
9975 Summers Ridge Road, San Diego, United States
BullYa
BullYa Mar. 19 at 6:56 PM
$QDEL it’s taking into the woodshed 📉
0 · Reply
BullYa
BullYa Mar. 19 at 5:51 PM
$QDEL 📉 $15 up for grabs
1 · Reply
goinbananas
goinbananas Mar. 17 at 2:26 PM
$QDEL Interesting… $ARKG $LABU $XBI
0 · Reply
BullYa
BullYa Mar. 16 at 3:26 PM
$QDEL probably 📉 $15 at eow or sooner 🚩
0 · Reply
BullYa
BullYa Mar. 13 at 4:50 PM
$QDEL 📉 $15 ?
0 · Reply
goinbananas
goinbananas Mar. 12 at 4:30 AM
$QDEL this thing is getting the crap kicked out of it. Meanwhile, beat on earnings and revenue last quarter, higher EPS expected Q1, etc. Looking to buy more. $ARKG $LABU $XBI
0 · Reply
BullYa
BullYa Mar. 11 at 8:57 PM
$QDEL taking advantage of oversold day to buy the dip cheap stock ✅💨🛫
0 · Reply
BullYa
BullYa Mar. 11 at 6:58 PM
$QDEL ✅ great price for starters.💨🛫
0 · Reply
BullYa
BullYa Mar. 11 at 5:39 PM
$QDEL ✅ buy the discount
0 · Reply
BullYa
BullYa Mar. 9 at 6:42 PM
$QDEL flat no bounce today 📉 🤷‍♂️ Probably support at $15 in a next few days
0 · Reply
Latest News on QDEL
Faster Cardiac Answers with High‑Sensitivity Troponin

Feb 19, 2026, 9:17 AM EST - 4 weeks ago

Faster Cardiac Answers with High‑Sensitivity Troponin

QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference

Feb 18, 2026, 4:05 PM EST - 4 weeks ago

QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference

QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript

Feb 11, 2026, 10:04 PM EST - 5 weeks ago

QuidelOrtho Corporation (QDEL) Q4 2025 Earnings Call Transcript

QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 11, 2026, 4:05 PM EST - 5 weeks ago

QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results

QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards

Feb 3, 2026, 7:12 AM EST - 6 weeks ago

QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards

Strengthening the blood supply: Awareness, challenges and donor impact

Jan 22, 2026, 7:12 AM EST - 2 months ago

Strengthening the blood supply: Awareness, challenges and donor impact

QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Jan 21, 2026, 7:00 AM EST - 2 months ago

QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results

Innovating Diagnostics and What's Next

Dec 18, 2025, 9:17 AM EST - 3 months ago

Innovating Diagnostics and What's Next

QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

Dec 3, 2025, 3:43 PM EST - 3 months ago

QuidelOrtho Corporation (QDEL) Presents at Citi Annual Global Healthcare Conference 2025 Transcript

QuidelOrtho To Participate In Upcoming Investor Conferences

Nov 24, 2025, 7:00 AM EST - 4 months ago

QuidelOrtho To Participate In Upcoming Investor Conferences

The Power of Prevention: Detecting Diabetes Before It Strikes

Nov 20, 2025, 9:00 AM EST - 4 months ago

The Power of Prevention: Detecting Diabetes Before It Strikes

QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 5:46 AM EST - 4 months ago

QuidelOrtho Corporation (QDEL) Q3 2025 Earnings Call Transcript

QuidelOrtho Reports Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 4 months ago

QuidelOrtho Reports Third Quarter 2025 Financial Results

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Nov 3, 2025, 7:00 AM EST - 4 months ago

QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

Oct 23, 2025, 6:45 PM EDT - 5 months ago

Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics

QuidelOrtho to Report Third Quarter 2025 Financial Results

Oct 22, 2025, 7:00 AM EDT - 5 months ago

QuidelOrtho to Report Third Quarter 2025 Financial Results

QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025

Oct 16, 2025, 8:30 PM EDT - 5 months ago

QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

Sep 25, 2025, 9:00 AM EDT - 6 months ago

Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

Sep 22, 2025, 7:00 AM EDT - 6 months ago

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

Aug 28, 2025, 7:30 AM EDT - 7 months ago

QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference

QuidelOrtho Completes Debt Refinancing

Aug 21, 2025, 4:30 PM EDT - 7 months ago

QuidelOrtho Completes Debt Refinancing

Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities

Aug 21, 2025, 9:00 AM EDT - 7 months ago

Science Bytes Podcast Explores How Diagnostics Can Help Protect Students and Communities

QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development

Aug 19, 2025, 4:05 PM EDT - 7 months ago

QuidelOrtho Welcomes Erich Wolff as Executive Vice President, Strategy & Corporate Development

QuidelOrtho Launches Certified Analyzer Program

Aug 13, 2025, 3:00 PM EDT - 7 months ago

QuidelOrtho Launches Certified Analyzer Program

QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 1:07 AM EDT - 8 months ago

QuidelOrtho Corporation (QDEL) Q2 2025 Earnings Call Transcript

QuidelOrtho Reports Second Quarter 2025 Financial Results

Aug 5, 2025, 4:10 PM EDT - 8 months ago

QuidelOrtho Reports Second Quarter 2025 Financial Results

QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™

Jul 29, 2025, 5:00 PM EDT - 8 months ago

QuidelOrtho Recognized with Three Awards in 2025 IMV ServiceTrak™

Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

Jul 24, 2025, 9:00 AM EDT - 8 months ago

Urgent Need for Early Detection in Drug Overdose Cases Highlighted in New Podcast

QuidelOrtho to Report Second Quarter 2025 Financial Results

Jul 22, 2025, 4:30 PM EDT - 8 months ago

QuidelOrtho to Report Second Quarter 2025 Financial Results

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

Jul 17, 2025, 7:00 AM EDT - 8 months ago

Real Labs, Actual Decisions With Actionable Six Sigma Metrics

QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)

Jul 14, 2025, 7:00 AM EDT - 8 months ago

QUIDELORTHO AND BÜHLMANN LABORATORIES AG ANNOUNCE AVAILABILITY OF FECAL CALPROTECTIN (FCAL®) TURBO AND FECAL PANCREATIC ELASTASE (FPELA®) TURBO ASSAYS ON VITROS™ SYSTEMS AS A MICROTIP™ PARTNERSHIP ASSAY (MPA)

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

Jul 7, 2025, 7:00 AM EDT - 9 months ago

QuidelOrtho Strengthens Leadership Team With Appointments of Senior Vice Presidents for Global Quality and Clinical & Regulatory Affairs

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

Jun 3, 2025, 4:10 PM EDT - 10 months ago

QuidelOrtho Announces Strategy to Accelerate Growth in Molecular Diagnostics

QuidelOrtho to Participate in Upcoming Investor Conferences

May 22, 2025, 4:30 PM EDT - 10 months ago

QuidelOrtho to Participate in Upcoming Investor Conferences

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

May 12, 2025, 9:30 AM EDT - 11 months ago

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript

May 7, 2025, 7:56 PM EDT - 11 months ago

QuidelOrtho Corporation (QDEL) Q1 2025 Earnings Call Transcript

QuidelOrtho Reports First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 11 months ago

QuidelOrtho Reports First Quarter 2025 Financial Results

QuidelOrtho to Report First Quarter 2025 Financial Results

Apr 23, 2025, 4:30 PM EDT - 11 months ago

QuidelOrtho to Report First Quarter 2025 Financial Results

QuidelOrtho® Introduces Results Manager™ System

Mar 10, 2025, 9:00 AM EDT - 1 year ago

QuidelOrtho® Introduces Results Manager™ System

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

Feb 24, 2025, 7:00 AM EST - 1 year ago

QuidelOrtho to Participate in the 46th Annual Raymond James Institutional Investor Conference

QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript

Feb 12, 2025, 7:50 PM EST - 1 year ago

QuidelOrtho Corporation (QDEL) Q4 2024 Earnings Call Transcript

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

Feb 12, 2025, 4:05 PM EST - 1 year ago

QuidelOrtho Reports Fourth Quarter and Full-Year 2024 Financial Results

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Jan 13, 2025, 9:00 AM EST - 1 year ago

QuidelOrtho Announces Preliminary Unaudited Revenue for Fourth Quarter 2024

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

Jan 7, 2025, 12:48 AM EST - 1 year ago

Kuehn Law Encourages Investors of QuidelOrtho Corporation to Contact Law Firm

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Dec 31, 2024, 7:00 AM EST - 1 year ago

QuidelOrtho to Present at the 43rd Annual J.P. Morgan Healthcare Conference

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Dec 10, 2024, 7:00 AM EST - 1 year ago

QuidelOrtho Announces Appointment of Two Independent Directors to its Board

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

Nov 20, 2024, 3:08 PM EST - 1 year ago

Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Nov 20, 2024, 8:06 AM EST - 1 year ago

Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

TGT POWL

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

Nov 19, 2024, 9:05 PM EST - 1 year ago

QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group

BullYa
BullYa Mar. 19 at 6:56 PM
$QDEL it’s taking into the woodshed 📉
0 · Reply
BullYa
BullYa Mar. 19 at 5:51 PM
$QDEL 📉 $15 up for grabs
1 · Reply
goinbananas
goinbananas Mar. 17 at 2:26 PM
$QDEL Interesting… $ARKG $LABU $XBI
0 · Reply
BullYa
BullYa Mar. 16 at 3:26 PM
$QDEL probably 📉 $15 at eow or sooner 🚩
0 · Reply
BullYa
BullYa Mar. 13 at 4:50 PM
$QDEL 📉 $15 ?
0 · Reply
goinbananas
goinbananas Mar. 12 at 4:30 AM
$QDEL this thing is getting the crap kicked out of it. Meanwhile, beat on earnings and revenue last quarter, higher EPS expected Q1, etc. Looking to buy more. $ARKG $LABU $XBI
0 · Reply
BullYa
BullYa Mar. 11 at 8:57 PM
$QDEL taking advantage of oversold day to buy the dip cheap stock ✅💨🛫
0 · Reply
BullYa
BullYa Mar. 11 at 6:58 PM
$QDEL ✅ great price for starters.💨🛫
0 · Reply
BullYa
BullYa Mar. 11 at 5:39 PM
$QDEL ✅ buy the discount
0 · Reply
BullYa
BullYa Mar. 9 at 6:42 PM
$QDEL flat no bounce today 📉 🤷‍♂️ Probably support at $15 in a next few days
0 · Reply
gvnbykplt1903
gvnbykplt1903 Mar. 9 at 4:08 PM
$QDEL after few years later just bought 100 shares more average is now $47 . I will sell it when break even. My bigest bad experince.
0 · Reply
iAm_Ernesto
iAm_Ernesto Mar. 7 at 5:38 PM
$QDEL is this stock dead??? Only reason I gambled on it was because insiders recently bought….
0 · Reply
BullYa
BullYa Mar. 2 at 3:42 PM
$QDEL support 📉 $20 🤷‍♂️
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 26 at 4:18 PM
$QDEL RSI: 27.30, MACD: -1.9212 Vol: 2.95, MA20: 25.71, MA50: 28.55 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BullYa
BullYa Feb. 26 at 4:01 PM
$QDEL 📉$21 👀
0 · Reply
StockBraker
StockBraker Feb. 25 at 3:58 PM
$QDEL I truly regret ever buying this one. Needs medical treatment.
0 · Reply
Estimize
Estimize Feb. 25 at 3:01 PM
Wall St is expecting 0.45 EPS for $QDEL Q1 [Reporting 05/13 AMC] http://www.estimize.com/intro/qdel?chart=historical&metric_name=eps&utm_co
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 21 at 10:00 PM
$QDEL Share Price: $22.49 Contract Selected: Dec 18, 2026 $20 Calls Buy Zone: $5.27 – $6.51 Target Zone: $8.53 – $10.42 Potential Upside: 53% ROI Time to Expiration: 299 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Chickenstick1
Chickenstick1 Feb. 20 at 7:38 PM
$QDEL These results were actually quite good. The market's bias is way overstated.
0 · Reply
Chickenstick1
Chickenstick1 Feb. 20 at 4:31 PM
$QDEL Several million dollars in tariff restitution.
0 · Reply
VolatilityControl
VolatilityControl Feb. 18 at 4:40 PM
$QDEL QuidelOrtho operates diagnostics platforms with cyclical testing demand. Margin recovery depends on cost control. Base business remains stable.
0 · Reply
Staska
Staska Feb. 18 at 4:30 PM
$QDEL Catalysts in Upcoming Quarters Looking ahead, our analysts are monitoring (1) the pace and impact of new platform launches, including VITROS 450 and LEX Diagnostics; (2) progress on procurement and facility optimization initiatives to support margin expansion; and (3) international market growth, particularly in Latin America, Asia Pacific, and OUS immunoassay tenders. Regulatory developments in China and the sustainability of Labs segment momentum will also be closely tracked.
0 · Reply